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Invertebrate model systems are powerful tools
for studying human disease owing to their genetic
tractability and ease of screening. We conducted a
mosaic genetic screen of lethal mutations on the
Drosophila X chromosome to identify genes required
for the development, function, and maintenance of
the nervous system. We identified 165 genes, most
of whose function has not been studied in vivo. In
parallel, we investigated rare variant alleles in 1,929
human exomes from families with unsolved Mende-
lian disease. Genes that are essential in flies and
have multiple human homologs were found to be
likely to be associatedwith human diseases.Merging200 Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc.the human data sets with the fly genes allowed us to
identify disease-associated mutations in six families
and to provide insights into microcephaly associated
with brain dysgenesis. This bidirectional synergism
between fly genetics and human genomics facilitates
the functional annotation of evolutionarily conserved
genes involved in human health.INTRODUCTION
Unbiased genetic chemical mutagenesis screens in flies have
led to the discovery of the vast majority of genes in develop-
mental signaling pathways (Nu¨sslein-Volhard and Wieschaus,
1980). Most genes important to these pathways have now
been shown to function as oncogenes or tumor suppressors
(Pastor-Pareja and Xu, 2013). Similarly, in some areas of neuro-
biology, genetic screens in flies have led to the discovery of
genes important to nervous system function including TRP chan-
nels, potassium channels, and pathways that affect diurnal
rhythmicity. Subsequent studies have identified many diseases
that are associated with mutations or deletions of human homo-
logs (Bellen et al., 2010). However, our molecular understanding
of neurological disorders such as neurodegenerative disease
has mostly relied on reverse genetics (Lu and Vogel, 2009).
Although some genes required for neuronal maintenance have
been identified from genetic screens for viable mutations that
exhibit shortened life span, electroretinogram defects, abnormal
phototaxis, and retinal histology defects, or temperature-sensi-
tive paralysis, no large-scale systematic screens to directly
probe neurodegeneration have been carried out, (reviewed
in Jaiswal et al., 2012). In addition, because of lethal phenotypes,
the role of numerous essential genes in neuronal maintenance is
not known. We therefore implemented a genetic mosaic screen
to identify essential genes required for neuronal maintenance on
the X chromosome.
One major limitation in chemical mutagenesis screens has
been the inability to systematically identify an abundance of
causative mutations. However, with the advent of numerous
mapping tools and whole-genome sequencing (WGS), it should
be possible to identify hundreds of causative mutations from a
single mutagenesis experiment in which a multitude of pheno-
types are scored in parallel for each mutation.
In humans, the study of Mendelian traits has led to the discov-
ery of thousands of disease genes. Currently, identification of
rare disease-causing mutations is rapidly evolving because
whole-exome sequencing (WES) technologies are driving the
process (Bainbridge et al., 2011a; Lupski et al., 2013). However,
the capability to detect rare variants in personal genomes has
provided a diagnostic challenge. Traditionally, the identification
of causative or associated genetic variation has relied on gene
identification in families or patient cohorts followed by genetic
studies in model organisms to define the function of the gene
in vivo. Several studies havemade use of phenotypic information
in Drosophila to identify genes associated with human diseases
or traits (Bayat et al., 2012; Neely et al., 2010). However, the large
number of variants detected by WES with poorly defined pheno-
typic consequencesmakes it challenging to tie a specific variant/
gene to a given disease phenotype. Yet, these rare variants have
a strong contribution to disease (Lupski et al., 2011). The inter-
pretation of such genome-wide variation is hindered by our
lack of understanding of gene function for the majority of anno-
tated genes in the human genome.
We identified mutations in 165 genes, most of which have not
been characterized previously in vivo. We provide data that
suggest this gene set can be utilized as a resource to study
numerous disease-causing genes. In addition, we present data
that there is a fundamental difference between ethyl methane-
sulfonate (EMS) screens and RNAi screens. Moreover, we
show that fly genes with more than one homolog are much
more likely to be associated with human genetic disorders.
Finally, we demonstrate that merging data sets—genes identi-
fied in the fly screen and rare variant alleles in the human homo-
logs in families with Mendelian disease—can assist in humandisease gene discovery and provide biological insights into dis-
ease mechanisms.
RESULTS
A Mosaic Genetic Screen on the X Chromosome
To isolate mutations in essential genes that are required for
proper development, function, and maintenance of the
Drosophila nervous system, we performed an F3 adult mosaic
screen on an isogenic (iso) y w FRT19A X chromosome (Figure 1
and Figures S1 and S2 available online). We mutagenized males
using a low concentration of ethyl methane-sulfonate (EMS),
established 31,530 mutagenized stocks, and identified 5,857
stocks that carry recessive lethal mutations. To identify a broad
spectrum of mutations and isolate genes that affect multiple bio-
logical processes, we screened for numerous phenotypes that
affect the nervous system. We also screened for seemingly
unrelated phenotypes, such as wing and pigmentation defects.
Genes that affect wing veins and notching have been shown to
play roles in critical pathways that affect numerous organs,
including the nervous system. To assess phenotypes in the tis-
sues of interest, we induced mitotic clones in the thorax and
wing with Ultrabithorax-flippase (Ubx-FLP) (Jafar-Nejad et al.,
2005) and in the eye with eyeless-flippase (ey-FLP) (Newsome
et al., 2000). We did not pursue mutations that caused cell
lethality or showed no/minor phenotypes (Figure 1A). While
these genes are clearly important, they are difficult to study
and these mutants were not kept. We selected 2,083 lethal lines
with interesting phenotypes for further characterization (Figures
1A and 1B).
In the Ubx-FLP screen, we assessed the number and size of
mechanosensory organs (bristles) on the fly cuticle to identify
genes required for neural development (Figures 1C and 1D and
S2A–S2C) (Charng et al., 2014). We also screened for alterations
in the color of bristles and cuticle to permit identification of genes
involved in dopamine synthesis, secretion, metabolism, or mela-
nization (Yamamoto and Seto, 2014) (Figure S2D). In addition,
we selected mutations that affect wing morphogenesis to isolate
genes that regulate core signaling pathways, including Notch,
Wnt, Hedgehog, and BMP/TGF-b (Bier, 2005) (Figures S2E–
S2J). Indeed, these pathways have been implicated in synaptic
plasticity and neuronal maintenance in both fly and vertebrate
nervous systems. In the ey-FLP screen, we assessed morpho-
logical defects in the eye and head to isolate genes involved in
neuronal patterning, specification, and differentiation (Figures
S2K–S2O). Moreover, we screened for mutations that cause
glossy eye patches (Figure S2P) or mutations that cause a
head overgrowth (Figures S2Q–S2S). Glossy eye phenotypes
are associated with mitochondrial mutations (Liao et al., 2006),
while head overgrowth is linked to genes in Hippo signaling,
TOR signaling, intracellular trafficking, and cell polarity/adhe-
sion, and these pathways are implicated in disorders such as
autism, intellectual disability, and neurodegenerative diseases
(Emoto, 2012; Saksena and Emr, 2009).
To isolate mutations that affect neuronal development, func-
tion, andmaintenance in the visual system, we recorded electro-
retinograms (ERGs) in mutant eye clones in 3- to 4-week-old flies
(Figures 1E–1I). By analyzing the on and off transients of ERGsCell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc. 201
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(Figure 1H), one can assess photoreceptor synaptic activity and
axon guidance. A loss or reduction in the amplitude of depolari-
zation (Figure 1G) is typically associated with genes that play a
role in phototransduction, loss of which typically causes retinal
degeneration (Wang and Montell, 2007). To identify mutations
that cause a progressive demise of neurons, we screened young
and old animals for ERG defects (Figures 1F and 1I). Ultrastruc-
tural defects in the photoreceptor terminals of young and old flies
were also examined in some mutants with strong ERG pheno-
types (Figures 1J–1M). Based on both the morphology screen
and the ERG screen, we attempted to map 1,918 mutations (Fig-
ures S1 and S3).
Mutation Identification
On the X chromosome, complementation testing requires a
genomic duplication on another chromosome to rescue male
lethality. We selected 21 large (0.5 Mb to 2 Mb) duplications
that cover 95% of the X chromosome (Cook et al., 2010),
crossed them into the mutant backgrounds, and rescued the
lethality of 1,385 mutations (Figure S3). This permitted mapping
of the lethality to 26 cytological intervals of the X chromosome.
Complementation tests between mutants with similar pheno-
types rescued by the same duplication allowed us to establish
complementation groups. We grouped 450 mutations into 109
multiple allele complementation groups. The remaining 935
mutant strains include single alleles and a large number of
mutations not yet assigned to complementation groups. To
map the genes, we first performed deficiency mapping and
Sanger sequencing. This allowed identification of the locus for
63 complementation groups. For the remaining groups and
single alleles, we performed WGS (Haelterman et al., 2014) and
rescued the phenotypes with molecularly defined 80 kb P[ac-
man] duplications (Venken et al., 2010). By using both ap-
proaches, we were able to map 614 mutations to 165 genes,
including 81 loci that have not been characterized in vivo (Tables
1 and S1) and are predicted to be involved in many diverse pro-
cesses based on gene ontology analysis (Figures S2T and S2U).
Chemical Mutagenesis versus RNAi Screens
Two of the phenotypes that we screened, bristle development
and depigmentation, allow a direct comparison between this
screen and a genome-wide RNAi screen (Mummery-Widmer
et al., 2009). This RNAi screen covered 80% of all X chromo-Figure 1. Summary of the Drosophila X Chromosome Screen
(A and B) Pie chart (A) and bar graph (B) of phenotypes scored in the screen. The n
may show more than one phenotype in (B).
(C and D) Examples of phenotypes observed in the notum. (C) Clones induced in
example of bristle loss in mutant clones (white arrows) (see Extended Experimen
(E–I) Examples of ERG traces frommutant clones in the eye. A typical ERG has an
arrow head). ERGswere recorded in young (1- to 3-day-old) and old (3- to 4-week-
difference. (F) ERGs showing amplitude reduction in aged flies. (G) ERGs showing
(H) ERGs showing no or very small on transient in both young and aged flies. (I) ERG
carrying mutant clones in eye.
(J–M) Ultrastructural analysis using transmission electron microscopy (TEM) on y
the rhabdomeres. (J) Young wild-type control eye: regular array of ommatidial str
mutant rhabdomeres showing intact structures. (L) Aged control eye tissue with
rhabdomeres.
See also Figures S1, S2, S3.some protein coding genes. Interestingly, only 14% of the
genes we identified in the bristle screen were also isolated in
the RNAi screen (Figures 2A and 2B). Similarly, only 18% of
the genes that we identified from the pigmentation screen
were also identified in the RNAi screen (Figures 2C and 2D).
Conversely, we did not identify the vast majority of genes that
were identified by RNAi. In addition, a comparison of our gene
list and those of two RNAi screens for wing margin (Saj et al.,
2010) and eye morphological defects (Oortveld et al., 2013),
show that these screens also identified very different sets of
genes (Figures 2E and 2F). In summary, chemical screens iden-
tify a distinctive set of genes when compared to RNAi-based
screens.
Links to Human Diseases Based on Online Mendelian
Inheritance in Man
We next sought to determine if the 165 genes we identified in
flies could enhance the understanding of human disease asso-
ciated genes. Strikingly, 93% (153) of the fly genes isolated have
homologs in humans (Tables 1 and S1; Figure 3A). This is a
strong enrichment (c2 = 129, p < 0.001) for evolutionarily
conserved genes between humans and flies when compared
to the whole fly genome as only 48% of all fly genes have human
homologs (Figure 3B). Moreover, the human homologs of 31%
(48/153) of the identified fly genes have been associated with
human disease in Online Mendelian Inheritance in Man
(OMIM), 79% (38/48) of which exhibit neurological signs and
symptoms (Figure 3A; Table S1). Of the genes that are
conserved but not yet associated with Mendelian diseases
with neurological symptoms, 65 genes have potential relation-
ships to neurologic diseases (Figure 3A; Table S2). Therefore,
the essential genes that we identified in this screen are highly
conserved andmany of their homologs have already been impli-
cated in human disorders, showing that the screening strategy
is effective.
Data analysis revealed a striking difference in the number of
genes associated with disease depending on the number of
human homologs for each fly gene. Fly genes that have a single
human homolog have many fewer disease genes represented in
the OMIM database than those that have more than one homo-
log. There is a 2-fold enrichment (c2 = 10.7, p < 0.001) of fly
genes with more than one human homolog associated with dis-
eases in the OMIM database compared to fly genes that haveumbers represent mutations in each phenotypic category. Note that one strain
a wild-type background, clone borders are marked by a white dotted line, (D)
tal Procedures).
on transient (blue arrows), depolarization (orange line) and an off transient (blue
old) flies for each genotype. (E) ERGof young or aged flies that show no obvious
amplitude and on- and off-transient reduction in both young and agedmutants.
s showing on and off transients that are either absent or very small in aged flies
oung (2-day-old) and aged (3-week-old) mosaic flies. Red arrowheads indicate
uctures with seven rhabdomeres surrounded by pigment (glia) cells. (K) Young
intact rhabdomeres. (M) Aged mutant eye tissue with a strong degeneration of
Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc. 203
Table 1. List of 165 Fly Genes and 259 Corresponding Human Homologs Identified from the Screen
Fly Gene Human Homologs (*OMIM) Fly Gene Human Homologs (*OMIM) Fly Gene Human Homologs (*OMIM)




AP-1g AP1G1, AP1G2, AP4E1* Crag DENND4A, DENND4B,
DENND4Cari-1 ARIH1
arm CTNNB1* Cyp4d2 CYP4V2*
Arp2 ACTR2 DAAM DAAM1, DAAM2 parvin PARVA, PARVB, PARVG
ATP7 ATP7A*, ATP7B* dlg1 DLG1, DLG2, DLG3*, DLG4 pck CLDN12
baz PARD3, PARD3B Dlic DYNC1LI1, DYNC1LI2 Pgd PGD*
ben UBE2N dor VPS18 phl ARAF, BRAF*, RAF1*
br - dsh DVL1, DVL2, DVL3 PI4KIIIalpha PI4KA
Brms1 BRMS1, BRMS1L Dsor1 MAP2K1*, MAP2K2* por PORCN*
cac CACNA1A*, CACNA1B
CACNA1E
dwg MZF1, ZSCAN22 pot -
Efr SLC35B4 PpV PPP6C
Cap SMC3* egh - Prosa4 PSMA7, PSMA8
car VPS33A eIF2B-ε EIF2B5* Psf3 GINS3
CDC45L CDC45L elav ELAVL1, ELAVL2, rap FZR1
Cdk7 CDK7 ELAVL3, ELAVL4 Rbcn-3A DMXL1, DMXL2
CG11409 - ewg NRF1 Rbcn-3B WDR7,WDR72*
CG11417 ESF1 fh FXN* Rbf RB1*, RBL1, RBL2
CG11418 MTPAP* fliI FLII Rhp RHPN1, RHPN2
CG12125 FAM73A, FAM73B flw PPP1CB RpII215 POLR2A
CG12991 - fs(1)h BRD2, BRD3, BRD4, BRDT RpS5a RPS5
CG13365 - Sas10 UTP3
CG14442 ZNF821 Fur2 PCSK5, PCSK6 schlank CERS1, CERS2, CERS3*,
CERS4, CERS5, CERS6CG14786 LRPPRC* Gtp-bp SRPR
CG15208 C21orf2 hfw - scu HSD17B10*
CG15896 KIAA0391 Hlc DDX56 Sec16 SEC16A, SEC16B
CG1597 MOGS* hop JAK1, JAK2*, JAK3*, TYK2* sgg GSK3A, GSK3B
CG1703 ABCF1 Hr4 NR6A1 shi DNM1, DNM2*, DNM3
CG1749 UBA5 Hsc70-3 HSPA5 sicily NDUFAF6*
CG17776 - Inx2 - skpA SKP1
CG17829 HINFP kdn CS Smox SMAD2, SMAD3*
CG18624 NDUFB1 l(1)1Bi MYBBP1A smr NCOR1, NCOR2
CG2025 NRD1 l(1)G0156 IDH3A SNF1A PRKAA1, PRKAA2
CG2918 HYOU1 l(1)G0222 ANKLE2 sno SBNO1, SBNO2
CG3011 SHMT1, SHMT2 l(1)G0230 ATP5D Sp1 SP7*, SP8, SP9
CG3149 RFT1* l(1)G0255 FH* stim STIM1*, STIM2
CG32649 ADCK3*, ADCK4 l(1)G0334 PDHA1*, PDHA2 svr CPD
CG32694 - Marf MFN1, MFN2* tay AUTS2
CG32795 TMEM120A, TMEM120B Mcm6 MCM6* temp PTAR1
CG34401 ZSWIM8 mew ITGA3*, ITGA6*, ITGA7* TH1 NELFCD
CG3446 NDUFA13* mRNA-cap RNGTT tko MRPS12
CG3704 GPN1 mRpL38 MRPL38 trr KMT2C, KMT2D*
CG3857 SMG9 mRpS25 MRPS25 ubqn UBQLN1, UBQLN2*,
UBQLN3, UBQLN4,
UBQLNL
CG4078 RTEL1* mRpS30 MRPS30
CG4165 USP16 mst MSTO1 Upf1 UPF1
CG42237 PLA2G3, PROCA1 mus101 TOPBP1 Upf2 UPF2
CG42593 UBR3 mxc NPAT Usf USF1, USF2
(Continued on next page)
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Table 1. Continued
Fly Gene Human Homologs (*OMIM) Fly Gene Human Homologs (*OMIM) Fly Gene Human Homologs (*OMIM)
CG42749 - Myb MYB*, MYBL1, MYBL2 Usp7 USP7
CG4407 FLAD1 mys ITGB1, ITGB2*, ITGB4*,
ITGB5, ITGB6, ITGB7, ITGB8
vnd NKX2-2, NKX2-8
CG4542 ALG8* Vps26 VPS26A, VPS26B
CG7065 - wapl WAPAL
CG7358 ZC3H13 N NOTCH1*, NOTCH2*, wds WDR5, WDR5B
CG8184 HUWE1* NOTCH3*, NOTCH4 wus DNAJC22
CG8636 EIF3G nej CREBBP*, EP300* Ykt6 YKT6
CG8949 WAC Nmd3 NMD3 Zpr1 ZNF259
CG9650 BCL11A, BCL11B, ZNF296 nonC SMG1 bCop COPB1
Chc CLTC, CLTCL1 Nrg CHL1, L1CAM*, NFASC,
NRCAM
b-Spec SPTB*, SPTBN1, SPTBN2*,
SPTBN4CkIIbeta CSNK2B
CkIa CSNK1A1, CSNK1A1L Nup93-1 NUP93 dCOP ARCN1
comt NSF oc CRX*, OTX1, OTX2*
Human genes associated with Mendelian disease are marked with an asterisk and bold type, the corresponding fly gene is shown in bold. See also
Tables S1, S5.only one human homolog, 47% versus 22% (Figure 3C). This
prompted us to assess if the bias is conserved for all fly genes.
We found that a similar bias holds throughout the genome. Fly
genes with more than one human homolog are more likely to
be associated with diseases in the OMIM database than those
with a single homolog, 40% versus 20% (c2 = 386, p < 0.001)
(Figure 3D and Extended Experimental Procedures). Indeed,
57 fly genes with more than one human homolog account for
100 diseases in the OMIM database (1.75 diseases per fly
gene), an 8-fold enrichment when compared to fly genes with
a single homolog (0.22 diseases per fly gene) (Figure 3E). This
enrichment is not simply due to an absolute increase in the total
number of human homologs because evolutionarily conserved
genes that have more than one homolog are three times more
enriched for OMIM diseases, 0.62 versus 0.22 diseases per hu-
man gene (Figure 3E). The difference between 1.75 and 0.62 is
due to the number of homologs. Indeed, there are on average
3 human homologs for every fly gene that has more than one
human homolog (data not shown). These data suggest that
evolutionary gene duplication with divergence and further
specialization of gene function may allow tolerance of mutation
and viability versus lethality.
Since all of the mutations we isolated cause homozygous
lethality, we analyzed the correlation between lethality, the num-
ber of human homologs, and their links to OMIM diseases for the
entire fly genome. The number of essential genes in Drosophila
has been estimated to be approximately 5,000 (Benos et al.,
2001). Currently only 2,000 essential genes in FlyBase have
transposable elements or EMS/X-ray-induced mutations (Mary-
gold et al., 2013), representing about 40% of all essential fly
genes. The proportion of essential genes varies with evolutionary
conservation: an estimated 11% of the genes that do not have
human homologs are essential, whereas 38% of the genes that
have a single human homolog are essential (c2 = 354, p <
0.001) (Figure 3F). Finally, an estimated 61% of the fly genes
with more than one human homolog are essential. These data
show that fly genes that have more than one human homologare more likely to cause lethality when mutated. Finally, human
homologs of essential genes in Drosophila are more likely to be
associatedwith human genetic diseases (c2 = 88, p < 0.001) (Fig-
ure 3G). Therefore, we conclude that genes that are essential in
flies and have multiple human homologs are the most likely to be
associated with human diseases, potentially due to gene dupli-
cation and redundancy.
Combining Fly and Human Mutant Screen Data Sets to
Identify Disease Genes
Wenext utilized the fly gene data set uncovered from the forward
genetic screen in combination with a human exome data set to
identify new human disease genes. We undertook a systematic
search of all the variants in the human homologs of the genes
identified from theDrosophila screen withinWES data generated
from undiagnosed cases of Mendelian diseases. This included
1,929 individuals in the Baylor-Hopkins Centers for Mendelian
Genomics (BHCMG) (Figure 4).
BHCMG uses next-generation sequencing to discover the ge-
netic basis of asmanyMendelian diseases aspossible (Bamshad
et al., 2012). The study population includes singleton cases with
sporadic disease, single families, and when possible, larger co-
horts of affected individuals with a range of rare Mendelian phe-
notypes. Awide rangeof disorders are under investigation (http://
www.mendelian.org/). In general, patients are recruited when a
Mendelian disease seems highly likely and all reasonable efforts
at a molecular diagnosis have failed. Due to the rare nature of the
phenotypes, information from other patients or additional biolog-
ical information from model organisms is required to fulfill the
burden of proof for gene/disease association in such cases. For
this reason, our Drosophila resource of mutant genes was inte-
grated with our human exome variant and Mendelian phenotype
(Hamosh et al., 2013) databases, and the combination approach
was used to solve some of the cases.
We analyzed 237 out of the 259 (Table 1) homologs of fly genes
identified through the X chromosome screen as they were vali-
dated at the time of analysis. We included all 237 genes,Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc. 205
Figure 2. Comparison of Results from This
EMS Screen and Previous RNAi Screens
(A and B) Venn diagram (A) and bar graph (B)
showing overlap between two screens for bristle
loss defects. The genes that were identified in the
EMS screen were also screened by RNAi (Mum-
mery-Widmer et al., 2009) and 10 caused a bristle
loss whereas 57 showed no phenotype or caused
lethality.
(C and D) Venn diagram (C) and bar graph (D)
showing overlap between two screens for
pigmentation defects (this screen and the RNAi
screen of Mummery-Widmer).
(E) Comparison of the results of these screens for
wing notching defects.
(F) Comparison of the results of these two screens
for eye morphological defects.regardless of whether they were previously identified to be asso-
ciated with Mendelian diseases in OMIM, to avoid any bias. We
filtered out variants reported as having greater than 1%allele fre-
quency in databases of control individuals (See Extended Exper-
imental Procedures). Under the assumption of a recessivemodel
data set, we included all variants that met these criteria and were
homozygous or had two heterozygous variants affecting the
same gene. The latter set was not tested for cis or trans orienta-
tion of the variants prior to analysis. A dominant model included
heterozygous variants. These were filtered evenmore stringently
for allele frequency such that only variants that had not been
observed in the control data sets were studied (Table S3).
To explore potential associations with disease, we prioritized
variants for segregation analysis within families (Figure 4).
We performed Sanger sequencing or explored segregation in
families for 64 variants in 24 genes within 34 individuals in the
recessive data set and found that 15 variants in 8 genes within
10 individuals fulfilled Mendelian expectations for recessive in-
heritance. Likewise, for the dominant data set, we explored the
segregation for 158 variants in 85 genes within 99 individuals.
We found 22 variants in 15 genes within 21 individuals that ful-206 Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc.filled Mendelian expectations of a domi-
nantly inherited disorder in the family un-
der investigation. Interestingly, 22/31
individuals in which the variant met Men-
delian expectations had a neurological
disease.
As a proof-of-principle, we report six
patients/families with mutations in three
genes. In addition, we identified 25 other
individuals in which the variant in the ho-
molog of the fly gene met Mendelian
expectation. Some of these individuals
were found to have candidate variants in
multiple genes, some had too few living
relatives for further study, and for others,
studies are ongoing. Therefore, a system-
atic search of variants within the genes
identified in the Drosophila screen was
able to identify and prioritize a subset ofvariants with Mendelian inheritance in families that could be
studied. Among these, we found examples of known disease
genes (DNM2), a novel disease association to a known disease
gene (CRX), and novel candidate genes for disease (ANKLE2).
DNM2 and Charcot-Marie-Tooth Neuropathy
Examination of a homolog of Drosophila shibire (shi), the gene
that encodes Dynamin, led to a molecular diagnosis for two indi-
viduals with heterozygous mutations in DNM2 (Figures S4A and
S4B). Both patientswere diagnosedwith a distal symmetric poly-
neuropathy consistent with Charcot-Marie-Tooth disease (CMT)
(See Extended Results). Mutations in DNM2 are associated with
CMT Type 2M (OMIM 606482), an axonal form primarily affecting
neurons (Figure S4C). Patient 1, the proband in Figure S4A, pre-
sented at age 12with hand tremor, calf cramps, lower limbpares-
thesias, and difficulty with heel walking. She is a member of a
family with three generations of neuropathy (Figure S4A), and
the heterozygous G358R variant cosegregated with CMT (Fig-
ure S4A). Patient 2, the proband in Figure 4B, (currently 88 years
old) presented at age 40 with lower extremity weakness. His
nerve conduction studies showed low amplitudes and borderline
Figure 3. Essential Fly Genes Associated
with More Than One Human Homolog Are
More Likely to be Linked to HumanDiseases
(A) Classification of genes identified in the
screen based on human homologs and associated
diseases.
(B) Classification of the whole fly genome ac-
cording to the same criteria as in (A).
(C and D) Relationship between the number of
human homologs per fly gene and their association
with human diseases for genes identified in the
screen (C) and the whole fly genome (D).
(E) The number of human homologs per fly gene
and their enrichment in OMIM associated human
diseases.
(F) Relationship between the number of human
homologs per fly gene and lethality in flies.
(G) Relationship between genes associated with
lethality in flies and OMIM associated human dis-
eases.
See also Table S2.slowed velocities. He carries an E341K mutation in DNM2 (Fig-
ure S4D). In addition toDNM2, WES revealed a variant in another
CMT gene, LRSAM1 in this patient (Figure S4B). Interestingly,
dominant as well as recessive mutations in LRSAM1 can cause
CMT2P (OMIM 614436). Hence, either one or a combination of
both genesmaycauseCMT in this family.While someclinical fea-
tures of the probandsmade diagnosis difficult, the phenotypes of
these cases were indeed consistent with CMT type 2.
CRX and Bull’s Eye Maculopathy
Examination of one of the human homologs of Drosophila ocelli-
less (oc, CRX in humans) led to the identification of three cases of
bull’s eye maculopathy associated with dominant CRX alleles.
oc encodes a homeobox transcription factor that regulates
photoreceptor development (Vandendries et al., 1996). Identi-
fying cases of bull’s eye maculopathy, a late-onset slowly pro-
gressive retinal disorder, with CRX alleles was surprising
because CRX is typically associated with much more severeCell 159, 200–214, Schildhood vision loss seen in dominant
cone-rod dystrophy, Leber congenital
amaurosis, and autosomal dominant reti-
nitis pigmentosa (OMIM 120970, 613829).
The three cases of bull’s eye maculop-
athy included two individuals with no fam-
ily history of retinal disease (patients 3 and
4) and onemultigenerational pedigree (pa-
tient 5 [S150X]) (Figure 5A). The affected
individuals in the family of patient 5 devel-
oped symptoms at age 50 (range 28–63
years), and three family members with
the S150X mutation had minimal symp-
toms at initial evaluation between the age
of 55–60. Despite having near normal
vision, ophthalmologic exam in the retina
of these individuals revealed advanced
bull’s eyemaculopathy with foveal sparing
explaining the modest effect on vision.Patient 5 exhibits retinal abnormalities (Figure 5B–B’), ab-
normal autofluorescence in the fundus (Figure 5C–C’), aber-
rant Optical Coherence Tomography (OCT, Figure 5D–D’) and
electroretinograms (Figure 5E), all consistent with bull’s eye
maculopathy. The three new alleles are all encoding predicted
truncations of the OTX transcription factor domain (Figure 5F).
Functional analysis of homozygous oc mutant clones reveal
that the ERGs in young animals are nearly normal (Figure 5G)
but defective in 7-day-old flies, including reduced amplitude
and loss of on transients (Figure 5G, blue arrows). This suggests
that the photoreceptors become impaired over time. In sum-
mary, the defects in flies and humans show similarities.
ANKLE2 and Microcephaly
The Drosophila screen identified a mutation in l(1)G0222, the ho-
molog of ANKLE2 (dAnkle2) (Table 1). The mutation causes a
loss of thoracic bristles and underdevelopment of the sensory
organs in clones (Figure 6A). The human WES data identifiedeptember 25, 2014 ª2014 Elsevier Inc. 207
Figure 4. Flowchart for Discovery and
Functional Studies of Disease Genes Using
the Drosophila Resource and Human Exome
Data
See also Table S3, Figure S4.variants in ANKLE2 in a family with apparent recessive micro-
cephaly (Figures 6B and 6C). The proband, patient 6, has an
extreme small head circumference, a low sloping forehead, pto-
sis, small jaw, multiple hyper- and hypopigmented macules over
all areas of his body, and spastic quadriplegia (Figure 6D–6H;
Extended Results, ‘‘Clinical Case Histories’’). During his first
year of life, he had unexplained anemia, and glaucoma. At 3
years, he had onset of seizures, and at 5.5 years, his weight
was 10.7 kg (4 SD), length 83.8 cm (6 SD) and fronto-occipital
circumference 38.2 cm (9 SD).
Brain MRI in the newborn period demonstrated a low fore-
head, several scalp ruggae, and mildly enlarged extra-axial
space with communication between the posterior lateral ventri-
cles and the mesial extra-axial space. Other brain abnormalities
included a simplified gyral pattern, mildly thickened cortex, small
frontal horns of the lateral ventricles with mildly enlarged poste-
rior horns of the lateral ventricles, and agenesis of the corpus
callosum. The brainstem and cerebellum appeared relatively208 Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc.normal (Figures 6G and 6H). A younger
sister born a year later had severe micro-
cephaly, spasticity, and similar hyper-
and hypopigmented macules over all
areas of her body. She died 24 hr after de-
livery from cardiac failure associated with
poor contractility, although the basis for
this was not known.
WES data of the proband, his affected
sister, and both parents revealed four
candidate genes that meet Mendelian
expectation and are expressed in the
CNS (Table S4). Table S4 shows the vari-
ants with their scores from four predic-
tions programs (Liu et al., 2011). ANKLE2
was prioritized as a good candidate. To
assess if dAnkle2 is involved in CNS
development, we examined the brains of
Drosophila mutant larvae. Brain size in
early third instar larval stages is similar to
that of controls (Figure S5A). However,
later in third larval stage, the brain be-
comes progressively smaller than control
larvae (Figure S5A and Figures 6I and J).
To confirm that dAnkle2 is an ortholog of
human ANKLE2, we ubiquitously ex-
pressed human ANKLE2 in mutant flies
and observed rescue of lethality and
the small brain phenotype (Figures 6K–
6L). These data indicate that ANKLE2
is implicated in CNS development and
its molecular function is evolutionarily
conserved.To explore the cause of the small brain phenotype in dAnkle2
mutants, we assessed defects in processes which can cause
small brain phenotypes: mitosis, asymmetric cell division, and
apoptosis (Rujano et al., 2013). The number of neuroblasts,
marked by Miranda (Ceron et al., 2001) is severely reduced in
late third instar brain lobes (Figures 6M–6O and S5B and S5C).
In the few neuroblasts that undergo division, the spindles are
properly oriented toward the polarity axis (Figures S5D and
S5E). In addition, centriole duplication, impaired in many primary
human microcephaly syndromes (Kaindl et al., 2010), is not
affected in dAnkle2 mutants (Figures S5F and S5G). Hence,
loss of dAnkle2 causes a severe reduction in neuroblast number
but does not seem to affect asymmetric division or centriole
number.
To assess proliferation in the CNS, we induced mitotic clones
of dAnkle2 in the brain and labeled them with Bromo-
deoxyuridine (BrdU)(Figures 6P–6R). As shown in Figure 6R,
BrdU incorporation is strongly reduced in mutant clones when
Figure 5. Mutations in CRX Cause Bull’s Eye Maculopathy
(A) Pedigree of the family of patient 5 (red arrow) with multiple individuals with bull’s eye maculopathy. The S150X mutation in CRX was identified in eight family
members. DNA was not available for family members for whom screening results are not indicated.
(B–D) Clinical phenotypes of patient 5. (B–B’) Fundus photography show fine granularity in the outer retina and speckled glistening deposits arranged in a ring
around the macula. Peripheral fundi appear unaffected. (C–C’) Autofluorescence images reveal a bull’s eye phenotype with hypofluorescent macula surrounded
by a hyperautofluorescent ring, suggesting a continuously atrophic macular area. (D–D’) Optical coherence tomography shows central loss of the outer nuclear
layer, ellipsoid line, external limiting membrane, and retinal pigment epithelium atrophy corresponding to area of hypoautofluorescence in (C–C’).
(E) ERG of the proband: Electroretinographic traces showed implicit time delay and amplitude reduction in both scotopic and especially photopic responses in
keeping with generalized cone-rod dysfunction.
(F) Structure of CRX protein and mutations in patients 3–5.
(G) ERG of control and ocmutant clone in 2-day-old and 7-day-old (in light) adult flies. Blue arrows indicate on transient in ERG. On transients are lost in 7-day-old
flies. The orange line indicates the amplitude of ERG.
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Figure 6. ANKLE2 and Microcephaly
(A) dAnkle2 mutant clone of the peripheral nervous system in the thorax of a fly. In wild-type tissue (GFP, shown in blue), sensory organs are comprised of four
cells marked by Cut (green), one of which is a neuron marked by ELAV (red). In the mutant clone (/, nonblue), the number of cells per sensory organ is reduced
to two and does not contain a differentiated neuron.
(B) Pedigree of the family of patient 6 (red arrow) with a severemicrocephaly phenotype. Both affected individuals inherited variants from both parents inANKLE2.
(C) Structure of ANKLE2 protein and mutations in patient 6. Abbreviations: transmembrane domain (TMD), LAP2/emerin/MAN1 domain (LEM), ankyrin repeats
(ANK).
(D and E) Clinical phenotypes of the proband with a severe sloping forehead, microcephaly, and micrognathia.
(F) Scattered hyperpigmented macules on the trunk.
(G) Sagittal brain MRI of the proband in infancy with severe microcephaly, agenesis of the corpus callosum and a collapsed skull with scalp ruggae.
(H) Axial brain MRI showing polymicrogyria-like cortical brain malformations.
(I–L) Third instar larval brain of (I) control (y w FRT19Aiso); scale bar, 100microns (J) dAnkle2mutant, and (K) dAnkle2mutant in which the human ANKLE2 cDNA is
ubiquitous expressed (Rescue). Note that brain lobe (arrow in I) size is reduced in dAnkle2 mutant (J) and the phenotype is rescued by ANKLE2 expression (K).
Relative brain lobe volume of control, dAnkle2, and rescue using 3D confocal images is quantified in (L).
(M–O) Larval CNS neuroblasts (arrowheads) in control and dAnkle2mutant. Neuroblasts are marked by Miranda (Mira, green), chromosomes in dividing cells are
marked by Phospo-Histone3 (PH3, blue), and spindles in dividing cells aremarked by a-Tubulin (aTub, red). Relative number of neuroblasts in control and dAnkle2
is shown in (O).
(P–R) BrdU incorporation (red) in control (P) and dAnkle2mutant clones (Q) marked byGFP (green, dotted lines) in larval brains. Differentiated neurons aremarked
by ELAV (blue). Neuroblast (nb), ganglion mother cells (gmc), and neurons (n) are marked. Quantification of relative BrdU incorporation is shown in (R).
(S–V) TUNEL assay in third instar larval brain lobes of (S) control, (T) dAnkle2mutant, and (U) Rescue. Quantification of TUNEL positive cells/volume (cell death) is
shown in (V).
In (L, O, R, and V), error bars indicated SEM, *** indicates a p value < 0.001 and ** indicates a p value < 0.01.See also Table S4, Figure S5.compared to wild-type clones, indicating that cell proliferation is
severely impaired. In addition, the mutant clones (Figure 6Q) that
contain a neuroblast and its progeny, the ganglion mother cells210 Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc.and neurons, contain many fewer cells than wild-type clones
(Figure 6P). Finally, we observe a dramatic increase in apoptotic
cells marked by TUNEL in the dAnkle2 mutant brain lobes
(Figures 6S, 6T, and 6V). This cell death is rescued by the expres-
sion of the human cDNA encoding ANKLE2 (Figures 6U and 6V).
Therefore, defects in proliferation and excessive apoptosis are
both contributing to the loss of CNS cells in dAnkle2.
DISCUSSION
Here we describe the generation of a large set of chemically
induced lethal mutations on the Drosophila X chromosome that
were screened for predominantly neurological phenotypes in
adult mosaic flies. The mutations were assigned to complemen-
tation groups, mapped, and sequenced to associate as many
genes as possible with specific phenotypes. We identified and
rescued the lethality associated with mutations in 165 genes us-
ing a variety of mapping and sequencing methods. These muta-
tions are available through the Bloomington Drosophila Stock
Center and provide a valuable resource to study the function of
human genes in Drosophila especially since 93% of the genes
are evolutionarily conserved in human.
This mutant collection contains 21 genes associated with hu-
man diseases for which no mutations were previously available.
The fly mutants thus enable the study of the basic molecular
mechanism of 26 human diseases, including Leigh syndrome
(CG14786/LRPPRC, l(1)G0334/PDHA1, and sicily/NDUFAF6),
congenital disorders of glycosylation (CG1597/MOGS, and
CG3149/RFT1), Usher syndrome (Aats-his/HARS), Friedreich
ataxia (fh/FXN), and amyotrophic lateral sclerosis (ubqn/
UBQLN2). Based on the gene list from the Drosophila screen,
we explored a database of 1,929 human exomes from a Mende-
lian disease resource of patients with rare diseases. We exam-
ined the personal genomes for rare variants of the fly homologs
and prioritized a subset of human rare variant alleles for segrega-
tion analysis. We report six families with distinct diseases in
which the variants segregate and are likely responsible for
causing the associated Mendelian disease.
The approach described here provides a valuable resource to
study the function of many disease genes in different tissues. We
propose that the screen strategy be expanded to the autosomes,
and a number of guiding principles should be considered based
on this study. First, the use of low concentrations of EMS is
important as it minimizes the number of second site lethal and
visible mutations (Haelterman et al., 2014). Second, screening
for lethal mutations hasmajor advantages as 93%of the isolated
genes that are essential for viability are conserved, whereas only
48% of all Drosophila genes have evolutionarily conserved hu-
man homologs. Third, the isolation of lethal mutations also
greatly facilitates genetic mapping. Fourth, screening for many
different phenotypes casts a broader net and permits isolation
of mutations in many different genes, a strategy that is also
used in mice (White et al., 2013). Fifth, analyzing different
phenotypes revealed that mutations in the majority of the genes
cause more than one phenotype, consistent with extensive
pleiotropism.
Comparison of the gene list identified from our EMS screen
and several RNAi screens have shown that these approaches
reveal very distinct sets of genes. There are multiple reasons
that may lead to this difference. For example, since our screen
was aimed at identifying mutations that cause lethality, wehave not screened for genes that are nonessential. Thus, a
number of genes that are nonessential but cause morpholog-
ical defects are missed in our screen. On the other hand,
RNAi may not be efficient or cause off-targeting effects (Green
et al., 2014; Mohr, 2014). Regardless of the methods that are
being used, rescue experiments and independent validation
are critical to determine that the phenotype one observes is
due to loss of the gene of interest when performing a genetic
screen.
It is interesting to note that from our screen, essential fly genes
with two or more homologs in humans have a significantly higher
likelihood of being associated with Mendelian diseases than
those that only have a single human homolog (Figure 3). This
suggests that gene duplications of essential genes and sub-
sequent evolutionary divergence may lead to genes that are
partially redundant and more likely to be disease associated.
Hence, when analyzing human exomes, it would seem more
productive to start with homologs of evolutionarily conserved
essential Drosophila genes that have two or more human homo-
logs. In addition to these relationships to Mendelian traits, 17%
(26/153) of the fly genes that have human homologs have been
identified in GWAS (genome-wide association studies) for neuro-
logical disorders (Table S5). Hence, the collection of mutations
described here may permit us to study genes for complex traits.
We uncovered a genetic basis in a few cases for which the
gene was previously known. For example, the study of DNM2
revealed previously studied phenotypes associated with muta-
tions in the gene (CMT, Figure S4). In another case we
observed that mutations in a gene caused unexpected pheno-
types. Indeed, we identified three families with bull’s eye mac-
ulopathy, a condition that is much milder and with a later age of
onset than conditions typically associated with CRX truncations
such as Leber congenital amaurosis (leading to blindness
before a year of life) and cone rod dystrophy (a condition with
onset in the first or second decade). Interestingly, other trun-
cating alleles have been reported both N- and C-terminally to
the OTX transcription factor domain in patients with these se-
vere phenotypes. Therefore, while CRX mutations can produce
variable phenotypes (Huang et al., 2012), bull’s eye maculop-
athy has not been associated with deleterious CRX variants.
Our data suggest that some symptoms may manifest at older
ages, and the phenotypic spectrum of CRX mutations includes
late-onset mild retinopathy.
We identified deleterious alleles in ANKLE2 in two individuals
in a family affected by severemicrocephaly. In flies, we observed
severe defects in neuroblast proliferation and excessive
apoptosis in the third instar larval brain of dAnkle2 mutants.
This knowledge, combined with the observation that expression
of human ANKLE2 in dAnkle2 mutants rescues lethality, brain
size, and apoptosis, provide strong evidence that ANKLE2 is
responsible for the microcephaly in the family. Moreover,
ANKLE2 has been shown to physically and genetically interact
with VRK1 in C. elegans and vertebrates (Asencio et al., 2012),
and loss of fly VRK1 (also known as ballchen (ball) or nhk-1 in
flies) also causes a small brain phenotype in third instar larvae
(Cullen et al., 2005). It is therefore interesting to note that muta-
tions in VRK1 also cause microcephaly in patients (Figure S5H)
(Gonzaga-Jauregui et al., 2013).Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc. 211
The pattern of brain abnormalities and microcephaly in our
patient with ANKLE2 mutations is somewhat similar to patients
with autosomal recessive CLP1 mutations. CLP1 encodes an
RNA kinase involved in tRNA splicing (Karaca et al., 2014;
Schaffer et al., 2014). TheClp1 homozygous kinase-deadmouse
exhibits microcephaly that worsens with age due to apoptosis.
Hence, apoptosis may be a common denominator in these forms
of microcephaly.
Phenotypic information of Drosophila mutants allows re-
searchers to understand the potential in vivo function of their
human homologs. The cases of oc/CRX and dAnkle2/ANKLE2
are examples in which some direct phenotypic comparisons
are possible between the fly mutant and human conditions.
However, one of the major drawbacks of comparing phenotypes
in different species is that a comparison between different tis-
sues and organs is not always obvious. How do we relate wing
vein defects or a rough eye with the phenotypes observed in hu-
man genetic diseases? Numerous strategies have been outlined
by Lehner (Lehner, 2013) and one of the most compelling strate-
gies is based on orthologous phenotypes or phenologs (McGary
et al., 2010). Genes tend to work in evolutionarily conserved
pathways, allowing the direct transfer from genotype-phenotype
relations between species. For example, mutations in a subset of
genes that function in mitochondrial quality control cause a high
incidence of muscle mitochondrial defects in adult flies and Par-
kinson disease (PD) in humans (Jaiswal et al., 2012), suggesting
that new genes that affect muscle mitochondria in adult flies are
good candidates for PD. Indeed, it may well be that phenotypic
similarities between fly and man will be the exception rather than
the rule. Regardless, we provide evidence that the use of unbi-
ased screens in the fly and the resulting genetic resources will
provide opportunities to prioritize human exome variants and
to explore the underlying function of these and many other dis-
ease-causing genes in vivo.
EXPERIMENTAL PROCEDURES
Fly Strains
The strains used in this study including the mutations and duplications and
deletion strains used for mapping are described in Flybase (Marygold et al.,
2013) (see also Extended Experimental Procedures).
Isogenization and Mutagenesis
Isogenization of y w FRT19A chromosome was performed using standard ge-
netic crosses. Mutagenesis was performed by feeding isogenized y w FRT19A
isomales with sucrose solution containing a low concentration (7.5–10 mM) of
EMS as described (Bo¨kel, 2008). After recovery from mutagenesis, these
males were mated en masse with Df(1)JA27/FM7c Kr > GFP virgin females
for 3 days. In the F1 generation, y w mut* FRT19A/FM7c Kr > GFP (mut* indi-
cates the EMS-induced mutation) virgins were collected and 33,887 individual
females were crossed with FM7c Kr > GFP males to establish independent
balanced stocks. A total of 5,859 lines carried lethal mutations and the remain-
ing stocks were discarded.
Complementation and Mapping
Lines that exhibited a strong morphological and/or ERG phenotype were sub-
jected initially to duplication mapping. Subsequently, lines that were rescued
by the same duplication and exhibit similar phenotypes were crossed inter
se to establish complementation groups based on lethality. Complementation
groups were further fine mapped using deficiencies that cover the region of
interest.212 Cell 159, 200–214, September 25, 2014 ª2014 Elsevier Inc.Gene Identification
When a complementation group was mapped to a small region (30–300 kb,
varies depending on available resources), we searched for publically available
lethal mutations that map to the same region using FlyBase (Marygold et al.,
2013). We performed complementation tests using >1 mutant allele when
possible. For complementation groups that complemented all available lethal
mutations in the region, we performed Sanger sequencing using standard
methods. To expedite gene identification we also used Illumina-based
whole-genome sequencing technology (Haelterman et al., 2014)
Ethics Statement
Informed consent was obtained prior to participation from all subjects or
parents of recruited subjects under an Institutional Review Board approved
protocol at BCM.
Study Subjects
The analysis of 1,929 exomes fromBHCMGdescribedwasperformed in a data-
base from the WES of over 160 separate phenotypic cohorts. The sequencing
data included family-based studies inwhich both affected and unaffected family
members were sequenced, single individuals with unique phenotypes, as well
as larger cohorts of up to 50–60 cases with the same phenotype. Selection of
subjects was performed by a phenotypic review committee based on the likeli-
hood of the Mendelian inheritance for the disease phenotype.
Whole-Exome Capture, Sequencing and Data Analysis
All of the subjects enrolled in the BHCMG underwent WES using methods pre-
viously described (Lupski et al., 2013) (Extended Experimental Procedures).
Produced sequence reads were mapped and aligned to the GRCh37 (hg19)
human genome reference assembly using the HGSC Mercury analysis pipe-
line (http://www.tinyurl.com/HGSC-Mercury/). Variants were determined and
called using the Atlas2 suite to produce a variant call file (VCF). High-quality
variants were annotated using an in-house developed suite of annotation tools
(Bainbridge et al., 2011a).
ANKLE2 Construct and Transgenesis
Human ANKLE2 cDNA was cloned into pUASTattB (Bischof et al., 2007)
tagged vectors (N-terminal FLAG) using In-Fusion HD Cloning Kit (Clontech)
and vector was linearized with NotI and XhoI. The construct was inserted in
VK33 (Venken et al., 2006).
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and patient 6 family data (LR06-300a2, LR06-300f, LR06-300m) are in
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